A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy

A high secretion of follicle-stimulating hormone (FSH) in reproductive-aged women is unusual. We report a case of recurrent corpus luteum hemorrhage and subsequent ovarian torsion with markedly elevated FSH levels in a reproductive-aged woman in the absence of functional gonadotroph adenoma (FGA) or...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshihide Inayama, Koji Yamanoi, Baku Nakakita, Shimpei Shitanaka, Jumpei Ogura, Tsutomu Ohara, Mie Sakai, Haruka Suzuki, Koji Yasumoto, Ichiro Kishimoto, Yusuke Sagae, Yoshimi Kitawaki, Koh Suginami
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2020/4098085
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546919174373376
author Yoshihide Inayama
Koji Yamanoi
Baku Nakakita
Shimpei Shitanaka
Jumpei Ogura
Tsutomu Ohara
Mie Sakai
Haruka Suzuki
Koji Yasumoto
Ichiro Kishimoto
Yusuke Sagae
Yoshimi Kitawaki
Koh Suginami
author_facet Yoshihide Inayama
Koji Yamanoi
Baku Nakakita
Shimpei Shitanaka
Jumpei Ogura
Tsutomu Ohara
Mie Sakai
Haruka Suzuki
Koji Yasumoto
Ichiro Kishimoto
Yusuke Sagae
Yoshimi Kitawaki
Koh Suginami
author_sort Yoshihide Inayama
collection DOAJ
description A high secretion of follicle-stimulating hormone (FSH) in reproductive-aged women is unusual. We report a case of recurrent corpus luteum hemorrhage and subsequent ovarian torsion with markedly elevated FSH levels in a reproductive-aged woman in the absence of functional gonadotroph adenoma (FGA) or premature ovarian failure (POF). A 22-year-old nulligravid woman with a history of bilateral hemorrhagic corpus luteum and subsequent ovarian torsion presented with acute abdominal pain. An emergency salpingo-oophorectomy of the right side was performed, and the right ovarian torsion due to hemorrhagic corpus luteum was diagnosed. Laboratory tests revealed markedly elevated FSH levels (77.6 mIU/mL). FGA was suspected, but no evidence of tumor was identified. The left ovary enlarged again at one-month follow-up. Estrogen/gestagen therapy (EGT) was started, which reduced the enlarged ovary to normal size. Two years later, her pituitary hormonal status was evaluated in detail. Besides markedly elevated FSH level, slightly elevated LH (31.2 mIU/mL), normal total inhibin B (35.3 pg/ml), abnormally low anti-Müllerian hormone (AMH) (<0.03 ng/mL), and poor FSH response to gonadotropin-releasing hormone stimulation test were found. In the absence of FGA, we conclude that certain disorders of inhibitory factors for FSH function, including inhibin and AMH may exist, which could attribute to the patient’s symptoms. EGT was very effective in suppressing the ovarian hyperactivity.
format Article
id doaj-art-0124d66546bf44bd975f3cb2217161e3
institution Kabale University
issn 2090-6684
2090-6692
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Case Reports in Obstetrics and Gynecology
spelling doaj-art-0124d66546bf44bd975f3cb2217161e32025-02-03T06:46:38ZengWileyCase Reports in Obstetrics and Gynecology2090-66842090-66922020-01-01202010.1155/2020/40980854098085A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen TherapyYoshihide Inayama0Koji Yamanoi1Baku Nakakita2Shimpei Shitanaka3Jumpei Ogura4Tsutomu Ohara5Mie Sakai6Haruka Suzuki7Koji Yasumoto8Ichiro Kishimoto9Yusuke Sagae10Yoshimi Kitawaki11Koh Suginami12Department of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Obstetrics and Gynecology, Toyooka Public Hospital, Hyogo, JapanDepartment of Endocrinology and Diabetes, Toyooka Public Hospital, Hyogo, JapanDepartment of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto 606-8507, JapanDepartment of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto 606-8507, JapanDepartment of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto 606-8507, JapanA high secretion of follicle-stimulating hormone (FSH) in reproductive-aged women is unusual. We report a case of recurrent corpus luteum hemorrhage and subsequent ovarian torsion with markedly elevated FSH levels in a reproductive-aged woman in the absence of functional gonadotroph adenoma (FGA) or premature ovarian failure (POF). A 22-year-old nulligravid woman with a history of bilateral hemorrhagic corpus luteum and subsequent ovarian torsion presented with acute abdominal pain. An emergency salpingo-oophorectomy of the right side was performed, and the right ovarian torsion due to hemorrhagic corpus luteum was diagnosed. Laboratory tests revealed markedly elevated FSH levels (77.6 mIU/mL). FGA was suspected, but no evidence of tumor was identified. The left ovary enlarged again at one-month follow-up. Estrogen/gestagen therapy (EGT) was started, which reduced the enlarged ovary to normal size. Two years later, her pituitary hormonal status was evaluated in detail. Besides markedly elevated FSH level, slightly elevated LH (31.2 mIU/mL), normal total inhibin B (35.3 pg/ml), abnormally low anti-Müllerian hormone (AMH) (<0.03 ng/mL), and poor FSH response to gonadotropin-releasing hormone stimulation test were found. In the absence of FGA, we conclude that certain disorders of inhibitory factors for FSH function, including inhibin and AMH may exist, which could attribute to the patient’s symptoms. EGT was very effective in suppressing the ovarian hyperactivity.http://dx.doi.org/10.1155/2020/4098085
spellingShingle Yoshihide Inayama
Koji Yamanoi
Baku Nakakita
Shimpei Shitanaka
Jumpei Ogura
Tsutomu Ohara
Mie Sakai
Haruka Suzuki
Koji Yasumoto
Ichiro Kishimoto
Yusuke Sagae
Yoshimi Kitawaki
Koh Suginami
A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy
Case Reports in Obstetrics and Gynecology
title A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy
title_full A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy
title_fullStr A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy
title_full_unstemmed A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy
title_short A Case of Recurrent Hemorrhagic Corpus Luteum with Elevated Follicle-Stimulating Hormone, Controlled by Estrogen/Gestagen Therapy
title_sort case of recurrent hemorrhagic corpus luteum with elevated follicle stimulating hormone controlled by estrogen gestagen therapy
url http://dx.doi.org/10.1155/2020/4098085
work_keys_str_mv AT yoshihideinayama acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT kojiyamanoi acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT bakunakakita acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT shimpeishitanaka acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT jumpeiogura acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT tsutomuohara acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT miesakai acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT harukasuzuki acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT kojiyasumoto acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT ichirokishimoto acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT yusukesagae acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT yoshimikitawaki acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT kohsuginami acaseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT yoshihideinayama caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT kojiyamanoi caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT bakunakakita caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT shimpeishitanaka caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT jumpeiogura caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT tsutomuohara caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT miesakai caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT harukasuzuki caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT kojiyasumoto caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT ichirokishimoto caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT yusukesagae caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT yoshimikitawaki caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy
AT kohsuginami caseofrecurrenthemorrhagiccorpusluteumwithelevatedfolliclestimulatinghormonecontrolledbyestrogengestagentherapy